Illumina, Inc. (ILMN)
NASDAQHealth CareMedical - Diagnostics & ResearchSnapshot 2026-09-04
$218.22-1.55%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - Diagnostics & ResearchSnapshot 2026-09-04
QuarterlyIQ Insights · ILMN
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||||
| Revenues | 4,493.0 | 4,343.0 | 4,372.0 | 4,504.0 | 4,526.0 | 3,239.0 | — | 3,543.0 | 3,333.0 | 2,752.0 | 2,398.0 | 2,220.0 | 1,861.4 | 1,421.2 | 1,148.5 | 1,055.5 | 902.7 |
| Total Revenues | — | — | — | — | — | — | — | — | — | 2,752.0 | 2,398.0 | 2,220.0 | 1,861.4 | 1,421.2 | 1,148.5 | 1,055.5 | 902.7 |
| Cost of Revenues | 1,510.0 | 1,473.0 | 1,511.0 | 1,760.0 | 1,372.0 | 1,036.0 | — | 1,076.0 | 1,033.0 | 926.0 | 732.0 | 671.0 | 563.6 | 509.3 | 375.0 | 346.4 | 301.2 |
| Gross Profit | 2,983.0 | 2,870.0 | 2,861.0 | 2,744.0 | 3,154.0 | 2,203.0 | — | 2,467.0 | 2,300.0 | 1,826.0 | 1,666.0 | 1,549.0 | 1,297.7 | 911.9 | 773.5 | 709.1 | 601.5 |
| Operating Expenses & Income | |||||||||||||||||
| Selling, General & Admin | 1,130.0 | 1,086.0 | 1,092.0 | 1,612.0 | 2,092.0 | 941.0 | — | 835.0 | 794.0 | 674.0 | 584.0 | 516.0 | 466.3 | 381.0 | 286.0 | 261.8 | 220.5 |
| R&D Expenses | 960.0 | 967.0 | 1,169.0 | 1,354.0 | 1,185.0 | 682.0 | — | 647.0 | 623.0 | 546.0 | 504.0 | 401.0 | 388.1 | 276.7 | 231.0 | 196.9 | 177.9 |
| Operating Income | 883.0 | 807.0 | (833.0) | (1,069.0) | (123.0) | 580.0 | — | 985.0 | 883.0 | 606.0 | 587.0 | 613.0 | 514.7 | 134.1 | 200.8 | 199.5 | 211.7 |
| Earnings from Continuing Operations | |||||||||||||||||
| Interest Expense | — | 101.0 | 100.0 | 77.0 | 61.0 | 49.0 | — | 52.0 | 57.0 | 37.0 | 33.0 | 43.0 | 41.7 | 39.7 | 37.8 | 34.8 | 24.6 |
| Interest & Investment Income | 38.0 | 40.0 | 46.0 | 58.0 | 0.0 | 41.0 | — | 75.0 | 44.0 | 19.0 | 10.0 | 5.0 | 3.9 | 4.9 | 16.2 | 7.1 | 8.4 |
| Net Interest Expenses | — | — | — | 19.0 | 61.0 | 8.0 | — | (23.0) | 13.0 | 18.0 | 23.0 | 38.0 | 37.8 | 34.8 | 21.6 | 27.7 | 16.2 |
| Other Non-Operating Income / Expenses | 132.0 | 279.0 | (346.0) | (48.0) | 1,007.0 | 276.0 | — | 133.0 | 11.0 | 437.0 | (26.0) | (30.0) | (66.0) | 25.2 | 21.9 | (66.4) | (26.3) |
| Asset Writedown | — | — | — | — | — | — | — | 23.0 | 23.0 | 23.0 | — | (2.0) | (2.0) | 25.2 | — | 0.0 | — |
| EBT, Incl. Unusual Items | 1,015.0 | 1,086.0 | (1,179.0) | (1,117.0) | 884.0 | 856.0 | — | 1,118.0 | 894.0 | 1,043.0 | 561.0 | 583.0 | 448.8 | 159.3 | 222.6 | 133.0 | 185.4 |
| Income Tax Expense | 190.0 | 236.0 | 44.0 | 44.0 | 122.0 | 200.0 | — | 128.0 | 112.0 | 365.0 | 133.0 | 125.0 | 95.4 | 34.0 | 71.4 | 46.4 | 60.5 |
| Net Income | |||||||||||||||||
| Minority Interest | — | — | — | — | 0.0 | 0.0 | — | (12.0) | (44.0) | (48.0) | (35.0) | (4.0) | — | — | — | — | — |
| Net Income | 825.0 | 850.0 | (1,223.0) | (1,161.0) | 762.0 | 656.0 | — | 1,002.0 | 826.0 | 726.0 | 463.0 | 462.0 | 353.4 | 125.3 | 151.3 | 86.6 | 124.9 |
| Per Share | |||||||||||||||||
| Basic EPS | 5.46 | 5.47 | (7.69) | (7.34) | 5.07 | 4.48 | — | 6.81 | 5.63 | 4.96 | 3.09 | 3.19 | 2.61 | 1.00 | 1.23 | 0.70 | 1.01 |
| Diluted EPS | 5.39 | 5.45 | (7.69) | (7.34) | 5.04 | 4.45 | — | 6.74 | 5.56 | 4.92 | 3.07 | 3.10 | 2.37 | 0.90 | 1.13 | 0.62 | 0.87 |
| Revenue per Share | 29.37 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 151.0 | 155.0 | 159.0 | 158.0 | 150.0 | 147.0 | — | 147.0 | 147.0 | 146.0 | 147.0 | 145.0 | 135.6 | 125.1 | 123.0 | 123.4 | 123.6 |
| Diluted Weighted Avg Shares | 153.0 | 156.0 | 159.0 | 158.0 | 151.0 | 148.0 | — | 149.0 | 149.0 | 148.0 | 148.0 | 149.0 | 149.0 | 139.9 | 133.7 | 138.9 | 143.4 |
| Supplemental | |||||||||||||||||
| EBITDA | — | 1,077.0 | (479.0) | (637.0) | 128.0 | 767.0 | — | 1,173.0 | 1,062.0 | 762.0 | 728.0 | — | — | — | — | — | — |
| EBIT | 883.0 | 807.0 | (833.0) | (1,069.0) | (123.0) | 580.0 | — | 985.0 | 883.0 | 606.0 | 587.0 | 613.0 | 514.7 | 134.1 | 200.8 | 199.5 | 211.7 |
| Effective Tax Rate | 18.7% | — | — | -3.9% | 13.8% | 23.4% | — | 11.4% | 12.5% | 35.0% | 23.7% | 21.4% | 21.3% | 21.3% | 32.1% | 34.9% | 32.6% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.